Analogously to GRN missense mutations in AD and FTD, CSF1R mutation penetrance may be influenced by APOE genotype, aging, disease duration, or comorbidities such as cerebrovascular accidents, for which CSF1R has been already shown to play a critical protective role (Luo et al., 2013). This evidence concerns the gene APOE and Alzheimer disease.